Skip to main content

MA Bradley

First name:
MA
Last name:
Bradley
Timmons, M. D., Bradley, M. A., Lovell, M. A., & Lynn, B. C. (2011). Procedure for the isolation of mitochondria, cytosolic and nuclear material from a single piece of neurological tissue for high-throughput mass spectral analysis. Journal Of Neuroscience Methods, 197(2), 279-82. https://doi.org/10.1016/j.jneumeth.2011.02.027 (Original work published 2011)
Lovell, M. A., Bradley, M. A., & Fister, S. X. 4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures. Journal Of Alzheimer's Disease : Jad, 32(1), 139-46. https://doi.org/10.3233/JAD-2012-120409 (Original work published 2012)
Weidner, A. M., Bradley, M. A., Beckett, T. L., Niedowicz, D. M., Dowling, A. L., Matveev, S. V., et al. RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer's disease. Plos One, 6(9), e24930. https://doi.org/10.1371/journal.pone.0024930 (Original work published 2011)
Lovell, M. A., Soman, S., & Bradley, M. A. (2011). Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mechanisms Of Ageing And Development, 132(8-9), 443-8. https://doi.org/10.1016/j.mad.2011.08.003
Bradley, M. A., Xiong-Fister, S., Markesbery, W. R., & Lovell, M. A. (2012). Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression. Neurobiology Of Aging, 33(6), 1034-44. https://doi.org/10.1016/j.neurobiolaging.2010.08.016
Bradley, M. A., Markesbery, W. R., & Lovell, M. A. (2010). Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radical Biology & Medicine, 48(12), 1570-6. https://doi.org/10.1016/j.freeradbiomed.2010.02.016 (Original work published 2010)